Budesonide Sustained-release Capsules(Everest Medicine)

布地奈德缓释胶囊(Everest Medicine)

Report date: 2025/11/27 15:17:45

Base Information

Drug NameBudesonide Sustained-release Capsules(Everest Medicine)
Drug Alias Name布地奈德缓释胶囊(2.2类改良型新药)
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsGlomerulonephritis, IGA
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGA
Inactive IndicationsN/A

Other Information

ATC CodeN/A